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Abstract
Colibacillosis, caused by avian pathogenic Escherichia coli (APEC) is a major problem for the poultry industry
resulting in significant losses annually. Previous work in our lab and by others has shown that the increased
serum survival gene (iss) is a common trait associated with the virulence of APEC. This gene was first
described for its contributions to E. coliserum resistance. However, recently published research has called the
contribution of iss to this trait into question. In the present study, the level of serum resistance conferred on an
E. coli isolate by iss is examined. Additionally, the contribution of λ bor gene to E. coli serum resistance is
studied, as iss is thought to be derived from bor and bor occurs commonly among E. coli. To better understand
the iss and bor contributions to serum resistance, a series of iss and bor mutants was generated. An iss deletion
(iss−) mutant showed a significant drop in its resistance to serum. Similarly, a bor mutant showed a drop in
serum resistance but not as drastic as that observed with the iss mutant, suggesting that isscontributes more to
serum resistance than bor in this E. coli strain. Also, when iss was reintroduced into the iss− mutant the wild-
type level of serum resistance was restored, confirming that the deletion of iss was responsible for the change
in resistance seen in the mutant.
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SUMMARY. Colibacillosis, caused by avian pathogenic Escherichia coli (APEC) is a major problem for the poultry industry
resulting in significant losses annually. Previous work in our lab and by others has shown that the increased serum survival gene (iss)
is a common trait associated with the virulence of APEC. This gene was first described for its contributions to E. coli serum
resistance. However, recently published research has called the contribution of iss to this trait into question. In the present study, the
level of serum resistance conferred on an E. coli isolate by iss is examined. Additionally, the contribution of l bor gene to E. coli
serum resistance is studied, as iss is thought to be derived from bor and bor occurs commonly among E. coli. To better understand
the iss and bor contributions to serum resistance, a series of iss and bor mutants was generated. An iss deletion (iss2) mutant showed
a significant drop in its resistance to serum. Similarly, a bor mutant showed a drop in serum resistance but not as drastic as that
observed with the iss mutant, suggesting that iss contributes more to serum resistance than bor in this E. coli strain. Also, when iss
was reintroduced into the iss2 mutant the wild-type level of serum resistance was restored, confirming that the deletion of iss was
responsible for the change in resistance seen in the mutant.
RESUMEN. Nota de Investigacio´n—Caracterizacio´n de una serie de mutantes transconjugadas de un aislamiento de Escherichia
coli para su resistencia al complemento del suero.
La colibacilosis causada por cepas pato´genas de Escherichia coli es un problema importante para la industria avı´cola, resultando
anualmente en pe´rdidas significativas. Trabajos previos en nuestro laboratorio y en otros han demostrado que el gen de resistencia
aumentada (por sus siglas en Ingle´s iss) es una caracterı´stica comu´nmente asociada con la virulencia de cepas pato´genas de
Escherichia coli. Este gen fue descrito en un principio por su contribucio´n a la resistencia de E. coli en el suero. Sin embargo,
investigaciones publicadas recientemente ponen en duda el aporte del gen iss a la resistencia de E. coli en el suero. En el presente
estudio, se examina el nivel de resistencia al suero (complemento) conferido por iss a un asilamiento de E. coli. Adicionalmente se
estudia la contribucio´n del gen l bor a la resistencia contra el suero, esto debido a que se asume que el gen iss proviene del gen bor y
que el gen bor esta comu´nmente presente en E. coli. Con la finalidad de entender mejor la contribucio´n de los genes iss y bor a la
resistencia a suero, se generaron una serie de mutantes de iss y bor. Una mutante por delecio´n de iss (iss-) mostro´ una disminucio´n
significativa en su resistencia al suero. Similarmente, una mutante de bor mostro´ una disminucio´n en su resistencia al suero, aunque
no tan dra´stica como la observada en la mutante iss, lo que sugiere que iss contribuye ma´s a la resistencia en suero en esta cepa de E.
coli. Adema´s, cuando iss se reintrodujo en la mutante iss- se reestablecio´ el nivel previo de resistencia al suero, confirmando que la
delecio´n del gen iss fue responsable del cambio en resistencia observado en la mutante.
Key words: iss, bor, Escherichia coli virulence, avian colibacillosis, Escherichia coli, APEC, Bor, complement resistance, Iss, serum
resistance
Abbreviations: APEC5 avian pathogenic Escherichia coli; LB5 Luria Bertani; PCR5 polymerase chain reaction; PG5 peptone
glucose
Colibacillosis accounts for multimillion dollar losses in the
poultry industry annually (1). Despite this fact, the basic
mechanisms of virulence used by avian pathogenic Escherichia coli
(APEC) to cause disease in poultry remain ill defined. However, the
ability of avian E. coli to resist the bactericidal effects of serum
complement appears to play a significant role in the development of
colibacillosis in poultry (13,16,25,26,27,28,33,36,37). Serum re-
sistance in E. coli has been related to several structural factors
including a K1 antigenic capsule (10,22), a smooth lipopolysaccha-
ride layer (11,14), and certain outer membrane proteins, including
TraT, Iss, and OmpA (3,5,8,9,34). Recent work in our laboratory
has shown that the presence of iss is strongly correlated with an
APEC isolate’s ability to cause disease in poultry (29,30).
The increased serum survival gene, iss, first described for its role in
the serum resistance associated with a ColV plasmid in a human E.
coli isolate, increases the virulence of an E. coli isolate for day-old
chicks 100-fold and its complement resistance over 20-fold
(2,4,8,9). Iss, the protein product of iss, is thought to occur as a 10
to 11 kD lipoprotein in the bacterial outer membrane (3,15). iss may
be a derivative of bor, a gene of bacteriophage l (2,3,8,15). Bor,
a lipoprotein of the cell envelope of E. coli l lysogens, appears to
confer complement resistance on these lysogens (2). Amino acid
sequences of Iss and Bor are about 90% identical (15).
The iss gene has recently been localized to large plasmids that typify
the APEC pathotype (17,20). To date, it is known that these iss-
containing APEC plasmids may encode ColV or ColBM. Regardless
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of the colicin encoded, these plasmids contain a pathogenicity island
characterized by possession of iss, several iron acquisition operons, and
other genes (17). These plasmids are often conjugative and confer
upon the recipient strain such traits as colicin production, aerobactin
production, and increased serum resistance (17).
Recently, Mellata et al. (24) questioned the role of iss/Iss in the
ability of an APEC isolate to resist serum complement. In their
study, strains that contained iss and traT genes but had lost their K1
or O serotype were not protected against the bactericidal effect of
serum. However, these strains were less sensitive to serum than iss
and traT negative control strains. Based on these results, the authors
concluded that Iss plays a limited role in the serum resistance of the
APEC strain they studied.
In an effort of clarify the role of Iss in E. coli complement
resistance and to better understand the mechanisms of APEC
virulence, a series of transconjugant iss and bor mutants of an APEC
isolate were studied (23).
MATERIALS AND METHODS
Bacterial strains. Strains used in this study are summarized in
Table 1 and include APEC-O2, an iss+ virulent APEC strain isolated
from the joint of a chicken with colibacillosis. APEC-O2 possesses
pAPEC-O2-R, a 101-kb, multidrug-resistance–encoding plasmid (19),
and pAPEC-O2-ColV, a 180-kb, ColV-encoding plasmid (20).
pAPEC-O2-ColV contains a 93-kb cluster of putative virulence genes,
which includes iss (20). Both plasmids are transmissible by conjugation
(19,20). Also, E. coli DH5a (7), a plasmidless, avirulent K12 strain that
is iss2 and bor+, and a series of mutants previously created (23) were
used in this study. Knockout mutants were created by deletion of iss
from pAPEC-O2-ColV in APEC-O2 and deletions of bor from the
chromosome of E. coli DH5a by a one-step inactivation method using
l-derived recombination proteins and polymerase chain reaction (PCR)
products. Transconjugants were generated using an APEC-O2 or
APEC-O2Diss as the plasmid donor and E. coli DH5a or DH5a Dbor as
the plasmid recipients (23). When not in use, these organisms were
stored at 270 C in brain heart infusion broth (Difco Laboratories,
Detroit, MI) with 10% glycerol. When in use, these organisms were
grown on either MacConkey or Luria Bertani (LB) agar (Difco)
overnight at 37 C.
Molecular cloning. For creation of pZCiss, the iss gene was amplified
using primers previously described (15). The amplified iss gene was
prepared for ligation using the Wizard PCR preps DNA purification
system (Promega, Madison, WI). The iss amplicon was ligated into
pGEM-T Easy, and the recombinant plasmid DNA was used to
transform E. coli JM109 competent cells according to the manufacturer’s
protocol (Promega). Plasmid DNA was purified from these transfor-
mants using the Wizard Plus Minipreps DNA Purification System
(Promega) and digested with NsiI and SacII for 2 hr at 37 C. Digests
were run in 1% low melt agarose gel, stained with ethidium bromide,
Table 1. Characteristics of strains used.
Isolate Description iss, bor content Reference
APEC-O2 Pathogenic E. coli isolate from a diseased bird; iss is present on
a transmissible 180-kb plasmid known as pAPEC-O2-ColV
iss, bor 20
DH5a E. coli K12 strain bor 7
DH5a Dbor bor2 isogenic mutant of DH5a none 23
TC4 Transconjugant iss, bor 23
TC4 Dbor Transconjugant mutant iss 23
TC4 Diss Transconjugant mutant bor 23
TC4 Dbor Diss Transconjugant mutant none 23
TC4 Diss + pZCiss Transconjugant mutant complemented with iss iss, bor This study
TC4 Dbor Diss + pZCiss Transconjugant mutant complemented with iss iss This study
Fig. 1. Growth in PG broth.
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and viewed under UV light. A 720-bp band, corresponding in size to the
predicted iss amplicon, was excised from the gel and purified from the
agarose using MinElute Gel Extraction Kit (Qiagen, Valencia, CA).
NsiI- and SacII-digested iss was ligated into pZC320 using standard
procedures (32) to form pZCiss. Ligations were transformed in E. coli
BL21 (DE3) using the calcium chloride method (31). Transformants
were selected on LB agar containing ampicillin (100 mg/ml).
Serum resistance assay by microtiter method. Strains were assessed
for their ability to resist the bactericidal effects of complement by
a microtiter plate method previously described (21). Briefly, 2-hr
cultures of isolates grown in LB broth were diluted to 105 colony-
forming units (CFU)/ml in peptone glucose (PG) broth. One hundred
microliters of these cultures was inoculated into flat-bottomed 96-well
microtiter plates. A 100-ml amount of 50% chicken serum diluted in
phosphate-buffered saline (35) was added to each well. Medium and
culture controls were also included. Plates were monitored for growth
using a microplate reader set at 490 nm. Plates were incubated at 37 C
and read every 30 min for 4 hr.
Serum resistance assay by plate count method. Strains were assessed
for their ability to resist the bactericidal effects of complement by a plate
count method previously described (21) in order to verify the results of the
microtiter method. The strains were grown overnight in a 2-ml culture of
LB broth. The next day, cell densities were calculated by spectropho-
tometry, and cultures were diluted in LB with 25% chicken sera to
a starting concentration of 103 CFU/ml, which was confirmed by viable
counts. Mixtures were incubated at 37 C with shaking. Samples were
taken every hour for 6 hr and plated on MacConkey agar to determine
viable counts. Results shown are the average of three trials. The
experiment was repeated using LB with no serum as a medium control.
Biostatistics. All growth rate data for the strains were analyzed using
linear regression analysis (Systat, Evanson, IL). The growth rates of each
E. coli strain were determined as previously described by Broughall et al.
(6). Briefly, all data were included from the point at which the cell
concentration had increased to 150% of the inoculated concentration to
the point where the population density ceased to increase. Specific
growth rates were calculated from the slopes of the generated regression
lines as described by Duffy et al. (12). A one-way ANOVA was used to
test the null hypothesis of equal mean growth rates among the strains. A
post hoc test, Fisher LSD, was used to identify differences between
specific strains with a Type I error rate of 5% (a 5 .05) for all tests.
RESULTS
Previously, a series of iss and bor transconjugant mutants were
created (23). In order to complement iss2 transconjugant mutants,
pZCiss was produced. The iss gene was first amplified and cloned
into pGEM-T Easy cloning vector. iss was then cleaved from
pGEM-T Easy and successfully cloned into pZC320. The construct
was termed pZCiss. This construct was successfully transformed into
iss2 transconjugant mutants and selected on ampicillin-containing
LB agar.
Growth rates amongst all the strains for the microtiter test,
including wild types, mutants, and complemented mutants, were not
statistically different in PG broth (Fig. 1). However, differences were
observed when strains were grown in serum. Deletion of iss from
pAPEC-O2-ColV significantly decreased the growth of the
transconjugants in chicken serum (Table 2, Fig. 2). Deletion of
bor from the chromosome of the transconjugants also significantly
decreased their growth in chicken serum (Table 2, Fig. 2). TC4
Dbor had a growth rate in chicken serum significantly higher than
DH5a, TC4 Diss, and TC4 Dbor Diss (p , .05 for all) but did not
attain the growth rate of TC4. TC4 Diss grew at a rate statistically
indistinguishable from TC4 Dbor Diss. Transconjugants with iss
deletions that were complemented with pZCiss attained wild-type
Table 2. Growth in normal serum using microtiter method.
Isolate Growth rate mean Growth rate classAA
TC4 0.052 A
TC4Diss + pZCiss 0.049 A
TC4 Dbor 0.030 B
TC4 Dbor Diss +
pZCiss
0.033 B
TC4 Diss 0.004 C
DH5a 0.000 C
TC4 Dbor Diss 0.000 C
AGrowth rates with the same letter are not significantly different
(P . .05), calculated using a one-way ANOVA.
Fig. 2. Growth in chicken serum (microtiter method).
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levels of serum resistance. That is, TC4 Diss + pZCiss grew at a rate
statistically indistinguishable from TC4, and TC4 Dbor Diss +
pZCiss grew at a rate statistically indistinguishable from TC4 Dbor.
Growth rates of the strains using the plate count method showed
similar results. Growth rates for all strains was not significantly
different in LB broth (results not shown), while differences in
growth rates were seen when grown in serum (Table 3, Fig. 3).
DISCUSSION
Previously we have found that the acquisition of pAPEC-O2-
ColV by E. coli DH5a increased its serum resistance, but the gene or
genes on the ColV plasmid responsible for the serum resistance
phenotype were not identified. Since iss, which has been associated
with serum resistance (4,5,8,9), has been localized to pAPEC-O2-
ColV (17) and pAPEC-O1-ColBM (18), and since these plasmids
typify the APEC pathotype (30), it seems likely that iss would
contribute to the increased serum resistance conferred by the ColV
plasmid. However, since genes other than iss, such as traT, which is
thought to contribute to serum resistance, occur on ColV plasmids,
we cannot be sure if increased serum resistance is due to the
possession of iss alone. Therefore, this study sought to determine the
level of serum resistance conferred on an isolate by possession of iss
using a series of previously created isogenic mutants (23). Also, since
iss and bor share about 90% homology (15), we wished to compare
the levels of serum resistance conferred on an E. coli strain by the
possession of bor and iss.
Transconjugants containing pAPEC-O2-ColVDiss were signifi-
cantly less resistant to serum than the wild-type transconjugant.
Indeed, the mutant’s ability to grow in serum was so impaired that
there was almost no growth at all. When bor was deleted from the
chromosome of DH5a, a significant decrease in serum resistance, as
compared to the wild-type transconjugant, was observed. However,
this decrease was not as large as that seen in the iss2 mutant,
suggesting that iss contributes more to the serum resistance of TC4
than does bor. When iss was reintroduced into the iss2 mutants, the
serum resistance of the mutant was restored to the wild-type
transconjugant level, confirming that the mutation of iss was
responsible for the change in the mutant’s complement sensitivity.
These results are interesting and seem to confirm the role of iss in the
complement resistance associated with ColV plasmids. Considering
that iss is found significantly more often in APEC isolates than in
avian commensal E. coli isolates (29,30), whereas bor is found in the
chromosome of most E. coli isolates. Since Iss and Bor both occur on
the outer membrane of the bacterium (23), are involved in serum
resistance (3,4,5,8,9), and have about 90% amino acid homology
(15), the difference in their contribution to serum resistance could
be due to the level of expression of the genes, with iss being up-
regulated over bor, or due to difference in protein structure.
Currently, research in our lab is focused on determining the levels of
gene expression by reverse transcriptase PCR to help answer this
question.
Fig. 3. Growth in chicken serum (plate count method). Growth in chicken serum of DH5a, the transconjugant and corresponding mutants,
and the iss-complemented mutants. Growth curves were determined by the plate count method and reflect an average of three trials for each strain.
Table 3. Growth in normal serum using plate count method
method.
Isolate Growth rate mean Growth rate classAA
TC4 1.09 A
TC4Diss + pZCiss 1.04 A
TC4 Dbor 0.87 B
TC4 Dbor Diss + pZCiss 0.85 B
TC4 Diss 0.61 C
DH5a 0.54 C
TC4 Dbor Diss 0.55 C
AGrowth rates with the same letter are not significantly different
(P . .05), calculated using a one-way ANOVA.
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The results from the plate count method verify the results of the
microtiter method. That is, we were able to arrange strains in groups
whose growth rates were not statistically different from each other. It
is interesting to note that while the groupings were the same between
the two methods, the growth rates were different using the two
methods. Using the microtiter method, strains TC4 Diss, DH5a,
and TC4 Dbor Diss showed little to no growth, but showed
considerable growth using the plate count method. While the
microtiter method is a fast and easy method to determine growth
rates, it may not be as accurate as a plate count method.
Recently, Mellata et al. (24) stated that Iss and TraT played
a limited role in complement resistance due to the fact that strains
containing iss and traT genes, but had lost the K1 or O serotype were
not protected against the bactericidal effect of serum. However, these
strains were less sensitive than iss2 and traT2 control strains. While
certainly there may be other chromosomal factors that contribute to
serum resistance, iss appears to play the major role in the serum
resistance associated with pAPEC-O2-ColV.
In summary, a series of iss and bor mutants were generated to
study the contributions of each gene to serum resistance. Deletion of
iss in a strain conferred a significant drop in its resistance to serum.
Similarly, a bor mutant showed a drop in serum resistance but not as
drastic as that observed with the iss mutant. Also, when iss is
reintroduced into the iss2 mutant, the wild-type level of serum
resistance was restored, confirming that the deletion of iss was
responsible for the change in resistance seen in the mutant.
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